Skip to content

Massive Iron Deposit Assessment

Massive Iron Deposit Assessment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01572922
Enrollment
142
Registered
2012-04-06
Start date
2012-06-11
Completion date
2018-02-28
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excessive Body Iron Burden, Iron Overload

Keywords

Sickle cell disease, Thalassemia, Hemochromatosis, Cancer

Brief summary

Iron overload is a severe complication of multiple blood transfusions. As the body has no physiologic mechanism for clearing iron, repeated transfusions cause iron accumulation in organs and lead to iron toxicity. Accurate assessment of iron overload is paramount to quantify excessive iron accumulation and to monitor response to iron chelation therapy. Magnetic resonance imaging (MRI) methods have been used to noninvasively measure hepatic iron concentration (HIC). Although MRI-based measurements of transverse relaxation rates (R2 and R2\*) accurately predict biopsy-proven HICs below 15 mg Fe/g, previous studies have shown that their precision is limited for HICs above 15 mg Fe/g and inaccurate above 25 mg Fe/g. Current R2\* gradient-echo (GRE) MR techniques fail occasionally for very high iron overloads (HIC \ 15-25 mg Fe/g) and always for massive iron overloads (HIC \> 25 mg Fe/g) because R2\* is so high that the MR signal decays before it can be measured accurately. Overall accrual: 200 patients Purpose: To determine if a new MRI (UTE) can measure the amount of iron in the liver of people with large amounts of iron and compare the results with the same patient's liver bx. Estimated patient accrual is 150. It is estimated that 41 of these patients will have clinical indication for liver biopsy.

Detailed description

The MIDAS study is a prospective and non-therapeutic study that will test a new MRI technique for the assessment of iron overload in the liver: the newly developed ultra short echo time (UTE), R2\*-UTE. The R2\*-UTE technique, developed by St. Jude investigators from the Department of Radiological Sciences, will be first tested in healthy volunteers for feasibility and implementation of the technique. The technique will then be tested in research participants, who will have both the R2\*-GRE and the R2\*-UTE techniques performed, in addition to a liver biopsy for liver iron quantitation if clinically indicated. Quantitation of liver tissue iron will be done at Mayo Clinic Laboratory in Rochester, Minnesota. Primary Objective: * To test the association of hepatic iron content (HIC) measured with the newly developed 1.5T R2\*-UTE technique and HIC quantified by liver biopsy in subjects with iron overload. Secondary Objectives: * To explore the relationship between 1.5T R2\*-UTE and 1.5T R2\*-GRE measurements in subjects with iron overload. * To explore the relationship between 1.5T R2\*-UTE measurements with iron studies (serum iron and transferrin saturation) in subjects with iron.

Interventions

DEVICER2*-UTE

Ultra short echo time (UTE) magnetic resonance imaging (MRI). Study participants will undergo an MRI examination of the liver on a 1.5T MRI and a 3T MRI scanner each. Because liver biopsy metal needle fragments could interfere with the MRI measurements, the MRI exams will always precede liver biopsy. Multi-echo GRE sequences will be used to acquire images with increasing TEs. Images of the liver will be obtained in transversal slice orientation through the center of the liver at the level of the origin of the main portal vein. At equivalent slice locations R2\*-UTE scans will be performed.

DEVICER2*-GRE

Gradient-echo (GRE) magnetic resonance imaging (MRI). Study participants will undergo an MRI examination of the liver on a 1.5T MRI and a 3T MRI scanner each. Because liver biopsy metal needle fragments could interfere with the MRI measurements, the MRI exams will always precede liver biopsy. Multi-echo GRE sequences will be used to acquire images with increasing TEs. Images of the liver will be obtained in transversal slice orientation through the center of the liver at the level of the origin of the main portal vein. At equivalent slice locations R2\*-UTE scans will be performed.

PROCEDURELiver biopsy

Indications for liver biopsy include, but are not limited, to the need to quantify liver tissue iron and the need to obtain histopathological information of the liver tissue. Liver biopsies will only be performed if clinically indicated and will be done only once per patient. The technique to be used is coaxial percutaneous (transcapsular) technique; however, a coaxial transjugular technique may be performed in subjects with increased bleeding diathesis, since it is associated with less hemorrhagic risk. Healthy volunteers will not undergo liver biopsy.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Regional One Health
CollaboratorOTHER
St. Jude Children's Research Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* History of 12 or more lifetime erythrocyte transfusions, AND * Need for liver iron content assessment (by MRI or liver biopsy)

Exclusion criteria

* Presence of certain MR-unsafe foreign material in the body, or other conditions that make the research participant ineligible for an MRI scan per St. Jude policies. * Any condition or chronic illness that in the opinion of the PIs makes participation on study ill-advised.

Design outcomes

Primary

MeasureTime frameDescription
Hepatic Iron Content in the Liver Using Liver Biopsyup to 30 days after MRIHepatic iron content in the liver using liver biopsy
MRI-derived R2* Values Using 1.5T UTE TechniqueUp to 30 days after MRIHepatic iron content of the liver using MRI-derived 1.5T R2\*-UTE measurement, with results in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Secondary

MeasureTime frameDescription
R2* Using 1.5T UTE Technique for Patients With Serum Iron and Transferrin Saturation MeasurementsUp to 30 days after MRIMRI-derived R2\* value using 1.5T R2\*-UTE in Hz for patients who have had serum iron and transferrin saturation measurements. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.
MRI-derived R2* Using 1.5T GRE TechniqueUp to 30 days after MRIMRI-derived R2\* Using 1.5T GRE Technique in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.
Transferrin Saturation MeasurementsUp to 30 days after MRIIron Transferrin Saturation in % measurements Transferrin Saturation measurements from eligible patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.
Serum Iron Measurements Compared With 1.5T R2* UTEUp to 30 days after MRISerum iron measurements from eligible patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.
MRI Derived R2* Using 1.5T UTE Techniqueup to 30 days after MRIMRI-derived R2\* value using 1.5T R2\*-UTE in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Countries

United States

Participant flow

Recruitment details

Patients within the St. Jude Network (St. Jude Children's Research Hospital, St. Jude Domestic Affiliates, and the adult Hematology and Oncology program at the University of Tennessee Health Sciences Center) who have history of 12 or more lifetime erythrocyte transfusions, and need for liver iron content assessment.

Pre-assignment details

One arm study

Participants by arm

ArmCount
Arm 1
All eligible patients with history of 12 or more lifetime erythrocyte transfusions, and need for liver iron content assessment
142
Total142

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall StudyDeath1
Overall StudyProtocol Violation1

Baseline characteristics

CharacteristicArm 1
Age, Categorical
<=18 years
85 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
57 Participants
Age, Continuous15.9 years
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
131 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
Race/Ethnicity, Customized
Asian
10 Participants
Race/Ethnicity, Customized
Black or African American
85 Participants
Race/Ethnicity, Customized
More than one race
1 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
6 Participants
Race/Ethnicity, Customized
White
40 Participants
Region of Enrollment
United States
142 Participants
Sex: Female, Male
Female
79 Participants
Sex: Female, Male
Male
63 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 142
other
Total, other adverse events
2 / 142
serious
Total, serious adverse events
1 / 142

Outcome results

Primary

Hepatic Iron Content in the Liver Using Liver Biopsy

Hepatic iron content in the liver using liver biopsy

Time frame: up to 30 days after MRI

Population: Eligible iron-overloaded patients with both liver biopsy measurement and 1.5T R2\*-UTE measurement.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsHepatic Iron Content in the Liver Using Liver Biopsy19.8 mcg
Primary

MRI-derived R2* Values Using 1.5T UTE Technique

Hepatic iron content of the liver using MRI-derived 1.5T R2\*-UTE measurement, with results in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Time frame: Up to 30 days after MRI

Population: Eligible iron-overloaded patients with both liver biopsy measurement and 1.5T R2\*-UTE measurement.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsMRI-derived R2* Values Using 1.5T UTE Technique864.4 Hz
Secondary

MRI-derived R2* Using 1.5T GRE Technique

MRI-derived R2\* Using 1.5T GRE Technique in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Time frame: Up to 30 days after MRI

Population: Iron-overloaded patients had 1.5T R2\*-GRE measurements.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsMRI-derived R2* Using 1.5T GRE Technique333.8 Hz
Secondary

MRI Derived R2* Using 1.5T UTE Technique

MRI-derived R2\* value using 1.5T R2\*-UTE in Hz. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Time frame: up to 30 days after MRI

Population: Iron-overloaded patients had 1.5T R2\*-UTE-measurement.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsMRI Derived R2* Using 1.5T UTE Technique319.2 HZ
Secondary

R2* Using 1.5T UTE Technique for Patients With Serum Iron and Transferrin Saturation Measurements

MRI-derived R2\* value using 1.5T R2\*-UTE in Hz for patients who have had serum iron and transferrin saturation measurements. R2\* is a measure obtained with MRI, i.e., MRI R2\*. It is measured in hertz (Hz). In lay terms, the MRI machine picks up a signal back from the tissue during the process of scanning the tissues. With every picture taken, this signal is strong in the beginning and then wanes off. R2\* reflects how fast the signal wanes off. If there is too much iron in the tissue, the signal disappears faster, making the T2\* value low. T2\* is the reciprocal of R2\* (R2\*= 1/T2\*). So, if the signal drops fast, the T2\* is low and the R2\* is high. In this study, we are measuring the R2\* value. The higher the R2\*, the more iron in the liver tissue. We can compare the R2\* value with that of a liver biopsy to then use the R2\* value to tell us how much iron is in the liver without having to biopsy the liver.

Time frame: Up to 30 days after MRI

Population: 1.5T R2\*-UTE from eligible patients who had 1.5T R2\*-UTE, serum iron, and transferrin saturation measurements.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsR2* Using 1.5T UTE Technique for Patients With Serum Iron and Transferrin Saturation Measurements340.8 Hz
Secondary

Serum Iron Measurements Compared With 1.5T R2* UTE

Serum iron measurements from eligible patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.

Time frame: Up to 30 days after MRI

Population: Iron-overloaded patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsSerum Iron Measurements Compared With 1.5T R2* UTE156.5 ug/dL
Secondary

Transferrin Saturation Measurements

Iron Transferrin Saturation in % measurements Transferrin Saturation measurements from eligible patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.

Time frame: Up to 30 days after MRI

Population: Iron-overloaded patients had 1.5T R2\*-UTE and serum iron and transferrin saturation measurements.

ArmMeasureValue (MEDIAN)
Iron-overloaded PatientsTransferrin Saturation Measurements71 percentage

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026